E-LIB Suche - Ergebnisse für: Hyland, Paula L

1

The Allied Health Expansion Program: Rethinking how to prep..:

Dalton, Lisa M. ; Hills, Andrew P. ; Jayasinghe, Sisitha...
Frontiers in Public Health. 11 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

2

New science, drug regulation, and emergent public health is..:

Chiu, Kimberly ; Racz, Rebecca ; Burkhart, Keith...
Frontiers in Medicine. 9 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

The impact of acute and chronic stress on gastrointestinal ..:

Leigh, Sarah‐Jane ; Uhlig, Friederike ; Wilmes, Lars...
The Journal of Physiology. 601 (2023) 20 - p. 4491-4538 , 2023

Link: https://doi.org/10.1113/..

4

New science, drug regulation, and emergent public health is..:

Chiu, Kimberly ; Racz, Rebecca ; Burkhart, Keith...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893027/. , 2023

Link: http://www.ncbi.nlm.nih...

5

New science, drug regulation, and emergent public health is..:

Kimberly Chiu ; Rebecca Racz ; Keith Burkhart...
https://www.frontiersin.org/articles/10.3389/fmed.2022.1109541/full. , 2023

Link: https://doi.org/10.3389/..

6

Table_2_New science, drug regulation, and emergent public h..:

Kimberly Chiu ; Rebecca Racz ; Keith Burkhart...
doi:10.3389/fmed.2022.1109541.s002. , 2023

Link: https://doi.org/10.3389/..

7

The Allied Health Expansion Program: Rethinking how to prep..:

Lisa M. Dalton ; Andrew P. Hills ; Sisitha Jayasinghe...
https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119726/full. , 2023

Link: https://doi.org/10.3389/..

8

Table_1_New science, drug regulation, and emergent public h..:

Kimberly Chiu ; Rebecca Racz ; Keith Burkhart...
doi:10.3389/fmed.2022.1109541.s001. , 2023

Link: https://doi.org/10.3389/..

9

Considerations for Use of Pharmacodynamic Biomarkers to Sup..:

Florian, Jeffry ; Gershuny, Victoria ; Sun, Qin...
Clinical Pharmacology & Therapeutics. 113 (2022) 2 - p. 339-348 , 2022

Link: https://doi.org/10.1002/..

10

Evaluating the Utility of Proteomics for the Identification..:

Hyland, Paula L. ; Chekka, Lakshmi Manasa S. ; Samarth, Deepti P....
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 98-107 , 2022

Link: https://doi.org/10.1002/..

11

Phase I clinical trial evaluating the safety and efficacy o..:

Blumenschein, George R ; Devarakonda, Siddhartha ; Johnson, Melissa...
Journal for ImmunoTherapy of Cancer. 10 (2022) 1 - p. e003581 , 2022

Link: https://doi.org/10.1136/..

12

Phase I clinical trial evaluating the safety and efficacy o..:

Victor Moreno ; Andrew Gerry ; Tom Holdich...
https://jitc.bmj.com/content/10/1/e003581.full. , 2022

Link: https://doi.org/10.1136/..

13

Phase I clinical trial evaluating the safety and efficacy o..:

Blumenschein, George R ; Devarakonda, Siddhartha ; Johnson, Melissa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796260/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Expanding Approved Patient Populations for Rare Disease Tre..:

Weaver, James L. ; Wu, Wendy ; Hyland, Paula L....
Clinical Pharmacology & Therapeutics. 112 (2021) 1 - p. 58-61 , 2021

Link: https://doi.org/10.1002/..

15

Expanding Approved Patient Populations for Rare Disease Tre..:

Weaver, James L ; Wu, Wendy ; Hyland, Paula L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293129/. , 2021

Link: http://www.ncbi.nlm.nih...